Drug fair Liu Jingzhen, chairman of Sinopharm group, and Tang Liangzhi, mayor of Chongqing met in depth to promote the integration of industry, research and medical industry, and promote the industrialization and innovation of medical devices

From December 4 to 6, the 82nd national drug Fair (Autumn) opened in Chongqing International Expo Center The national drug trade fair is an authoritative Trade Fair for pharmaceutical preparations, related technologies and services in China, and a grand brand event with a long history and a large scale in the field of Chinese medicine Many well-known pharmaceutical companies and manufacturers at home and abroad have gathered here to witness this grand occasion Liu Jingzhen, chairman of Sinopharm group, had an in-depth meeting with Tang Liangzhi, mayor of Chongqing, at the Chongqing pharmaceutical fair On behalf of the municipal government, Tang Liangzhi welcomed Liu Jingzhen and his delegation Mayor Tang said that he hoped that Sinopharm group would continue to increase its investment in Chongqing: "Sinopharm group is one of the world's top 500 enterprises, a large pharmaceutical and health industry group, and has built a large health industry chain Sinopharm group has maintained a good cooperative relationship with Chongqing It has developed well in Chongqing, and its investment has been increasing He hoped that Sinopharm group will continue to invest in Chongqing Deepen strategic cooperation with Chongqing, further accelerate the construction of cooperation projects, strengthen cooperation in medical devices, modern Chinese medicine and other fields, lay out more technologies and projects with core competitiveness and broad market prospects, and promote the development of Chongqing biomedical industry " Liu Jingzhen thanked Chongqing municipal government for its strong support to Sinopharm group: "Chongqing has outstanding location advantages, good business environment and huge development potential Sinopharm group will actively meet the development needs of Chongqing, strengthen the strategic layout, further improve the level of cooperation between the two sides, and help Chongqing's big health industry develop in high quality." The two sides also talked about: (1) strengthening high-level mutual visits between the two sides to enhance communication and exchanges and promote in-depth cooperation through mutual visits （2） Sinopharm group is one of the top 500 enterprises in the world and has a wide influence in the world Chongqing has a good foundation of biomedical industry At present, Chongqing is striving to build a national level biomedical industry base and has issued a series of industrial policies Sinopharm group and Chongqing have carried out a series of in-depth cooperation in industrial development, such as the layout of the "new medical industry chain" project focusing on medical innovation ecosystem, the integration of industry research and medical industry, and the promotion of modern medical device industrialization innovation, which plays an important role in promoting the development pattern and height of Chongqing medical device industry The two sides should establish a normal contact mechanism, further strengthen and expand the industrial cooperation between Sinopharm and Chongqing, further jointly promote the development of Chongqing biomedical industry, and achieve win-win results （3） To further promote the cooperative development, Chongqing Economic and Information Commission and Chongqing Science and technology bureau gave full support to the implementation of the "new medical industry chain" project, policy guidance, docking with local resources, etc., and also gave full support to the medical industry integration meeting, innovation and entrepreneurship competition, industry university research docking meeting, etc held by the "new medical industry technology innovation alliance" The Municipal Drug Administration has also provided a lot of guidance and support to the "new medical industry chain" project, which includes detailed regulations and guidance for ten innovative products, including exoskeleton rehabilitation robot, auxiliary hearing device, portable pressure gait sensor, chronic wound repair gel, microfluidic detection kit and so on After Chongqing was incorporated into the second batch of experimental provinces of MAH, Chongqing food and Drug Administration conducted a detailed investigation and Discussion on the product form, type and follow-up development direction of "new medical industry chain" On this basis, the SFDA will take the "new medical industry chain" as the first batch of MAH pilot units, support the implementation of various MAH Implementation Paths of the industry chain project, and meet the needs of supporting the development of the industry chain 37